2025-08-03 - Analysis Report
Okay, here's an analysis of Merck & Co Inc (MRK) based on the information you've provided, presented in English with key data points and brief commentary:

## MRK (Merck & Co Inc) Analysis

**Company Overview:** Merck & Co Inc is a global pharmaceutical company focused on developing and manufacturing medicines and vaccines.

**1. Performance vs. S&P 500 (VOO)**

*   **MRK Cumulative Return:** -9.96%
*   **VOO Cumulative Return:** 94.15%
*   **Relative Underperformance:** The cumulative return of MRK underperforms VOO by a significant margin, with a difference of -104.11%.
*   **Spread:** Current: -93.6 (Max: 40.3, Min: -93.6)
*   **Relative Spread Position:** 0.0 (Indicates the current spread is at the lowest end of its historical range).

**Alpha, Beta Analysis Table:**

| Year       | CAGR    | MDD    | Alpha    | Beta   | Cap(B) |
|------------|---------|--------|----------|--------|--------|
| 2015-2017  | 2.0%    | 0.0%   | -27.0%   | 7.6    | 134.8  |
| 2016-2018  | 33.0%   | 66.4%  | 15.0%    | -0.1   | 183.1  |
| 2017-2019  | 53.0%   | 66.4%  | 23.0%    | 0.0    | 217.9  |
| 2018-2020  | 19.0%   | 66.4%  | -1.0%    | 0.3    | 196.0  |
| 2019-2021  | -2.0%   | 65.6%  | -51.0%   | 0.3    | 192.4  |
| 2020-2022  | 13.0%   | 69.4%  | 10.0%    | 0.3    | 278.6  |
| 2021-2023  | 31.0%   | 69.4%  | 13.0%    | 0.3    | 273.8  |
| 2022-2024  | -7.0%   | 69.4%  | -33.0%   | 0.2    | 249.8  |
| 2023-2025  | -63.0%  | 71.5%  | -109.0%  | 0.5    | 199.1  |

**Analysis:**

*   **Significant Underperformance:** The substantial negative cumulative return and relative spread position of 0.0 suggest MRK has significantly underperformed the S&P 500.
*   **Alpha and Beta Trends:** Negative alpha values in several periods (especially recently) indicate underperformance relative to the market risk-free rate, while beta values fluctuate, suggesting varying degrees of market sensitivity.
*   **Maximum Drawdown (MDD):** High MDD values indicate substantial potential losses during the observed periods.
*   **Capitalization (Cap):** Fluctuations in market capitalization reflect changing investor sentiment and market conditions.
*   **CAGR:** Recent negative CAGR indicates poor growth in the most recent periods.

**2. Recent Stock Price Movements**

*   **Last Price:** 79.29
*   **Previous Close:** 78.12
*   **Change:** 1.5%
*   **5-Day Moving Average:** 81.17
*   **20-Day Moving Average:** 82.225
*   **60-Day Moving Average:** 79.7662

**Analysis:**

*   **Recent Price Increase:** The 1.5% increase from the previous close suggests a positive short-term movement.
*   **Moving Averages:** The current price is below the 5-day and 20-day moving averages, but slightly below the 60-day moving average. This mixed signal requires further investigation to determine the overall trend.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3358 (Low Risk)
*   **RSI:** 38.68 (Approaching oversold territory, potentially indicating a buying opportunity if other factors align)
*   **PPO:** -0.587 (Negative value suggests a downward trend in price momentum)
*   **Hybrid Signal:** Cash_70%_Sell 0.2% of holdings (Suggests a cautious approach with high cash reserves and slight selling)
*   **Recent (20-day) Relative Spread Change:** 0.0 (-): Short-term decline.
*   **Expected Return:** 282.0% (Long-term, relative to S&P 500)
*   **Recent Price Change:** The recent price change of 1.5% indicates a slight upward movement. This could be a short-term rebound, especially considering the broader context of underperformance.

**Analysis:**

*   **Low Risk (MRI):** A Market Risk Indicator of 0.3358 suggests the current market conditions pose low risk.
*   **Potential Buying Opportunity (RSI):** The RSI approaching oversold territory could signal a potential buying opportunity.
*   **Long-Term Potential (Expected Return):** A high expected return of 282.0% suggests significant potential for long-term outperformance compared to the S&P 500, but this should be weighed against recent underperformance.
*   **Short-term decline**: Recent (20-day) Relative Spread Change indicates a short-term decline.

**4. Recent News & Significant Events**

*   **July 30, 2025:** Major business developments, regulatory changes, or market events.
*   **August 1, 2025:** Analyst discussions on recent performance, industry trends, and global economic factors.
*   **August 3, 2025:** Stock volatility influenced by recent news, earnings reports, or executive actions.
*   **July 31, 2025:** Market experts highlight risks and opportunities, advising monitoring of news and announcements.

**Analysis:**

*   **Volatility and Uncertainty:** The news suggests recent volatility and ongoing discussions regarding the company's performance and outlook. These factors should be considered in any investment decision.

**5. Recent Earnings Analysis:**

| 날짜         | EPS   | 매출       |
|--------------|-------|------------|
| 2025-05-02   | 2.01  | 15.53 B$   |
| 2024-11-06   | 1.25  | 16.66 B$   |
| 2024-08-05   | 2.15  | 16.11 B$   |
| 2024-05-03   | 1.88  | 15.78 B$   |
| 2025-05-02   | 1.88  | 15.78 B$   |

**Analysis:**

*   **Fluctuating Earnings:** EPS and revenue have fluctuated over the past quarters. The earnings per share and revenue vary from quarter to quarter.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-03-31   | $15.53B  | 77.98%        |
| 2024-12-31   | $15.62B  | 75.50%        |
| 2024-09-30   | $16.66B  | 75.51%        |
| 2024-06-30   | $16.11B  | 76.76%        |
| 2024-03-31   | $15.78B  | 77.56%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE     |
|--------------|----------|---------|
| 2025-03-31   | $48.34B  | 10.51%  |
| 2024-12-31   | $46.31B  | 8.08%   |
| 2024-09-30   | $44.50B  | 7.09%   |
| 2024-06-30   | $43.58B  | 12.52%  |
| 2024-03-31   | $40.36B  | 11.80%  |

**Analysis:**

*   **Stable Profit Margins:** Profit margins have remained relatively stable over the observed quarters.
*   **Fluctuating ROE:** Return on Equity (ROE) has fluctuated, indicating variations in profitability relative to shareholders' equity.
*   **Equity Growth:** Equity has generally increased over the quarters, reflecting growth in the company's net assets.

**7. Overall Summary**

Merck & Co Inc (MRK) is currently showing mixed signals. While it has high profit margins, a low Market Risk Indicator, and potential long-term upside, it is currently underperforming the S&P 500 significantly. The recent news indicates volatility and ongoing evaluation, suggesting that the company is experiencing some changes or challenges. Recent financial data shows stable revenue and profit margins but fluctuating ROE. Given the significant underperformance and uncertain outlook, a cautious approach is warranted.
